(Q30307814)

16 June 2017

title

Molecular cloning, expression and modelling of cat allergen, cystatin (Fel d 3), a cysteine protease inhibitor (English)

1 reference

16 June 2017

Ichikawa K

1

1 reference

16 June 2017

Vailes LD

series ordinal

2

1 reference

16 June 2017

Pomés A

series ordinal

3

1 reference

16 June 2017

Chapman MD

series ordinal

4

1 reference

16 June 2017

publication date

1 August 2001

1 reference

Clinical & Experimental Allergy

16 June 2017

published in

1 reference

16 June 2017

volume

31

1 reference

16 June 2017

issue

8

1 reference

16 June 2017

page(s)

1279-1286

1 reference

Amino acid sequence of Fel dI, the major allergen of the domestic cat: protein sequence analysis and cDNA cloning.

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Expression and genomic structure of the genes encoding FdI, the major allergen from the domestic cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

A comparative study of the allergens of cat urine, serum, saliva, and pelt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Cat skin as an important source of Fel d I allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Fel d I allergen distribution in cat fur and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Effects of castration and testosterone on Fel dI production by sebaceous glands of male cats: II--Morphometric assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Defining allergens of mammalian origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Identification and clinical significance of allergenic molecules of cat origin. Part of the DAS 76 Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Cloning of cockroach allergen, Bla g 4, identifies ligand binding proteins (or calycins) as a cause of IgE antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Induction of IgE antibody responses by glutathione S-transferase from the German cockroach (Blattella germanica).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

The three-dimensional solution structure of human stefin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

The major dog allergens, Can f 1 and Can f 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Sequence of the gene encoding cat (Felis domesticus) serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

The cystatins: Protein inhibitors of cysteine proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Human cysteine-proteinase inhibitors: nucleotide sequence analysis of three members of the cystatin gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Allergy to lipocalins: a consequence of misguided T-cell recognition of self and nonself?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Allergy to mammalian proteins: at the borderline between foreign and self?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Proteolytic Cleavage of CD25, the α Subunit of the Human T Cell Interleukin 2 Receptor, by Der p 1, a Major Mite Allergen with Cysteine Protease Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

A mite subversive: cleavage of CD23 and CD25 by Der p 1 enhances allergenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Recombinant allergens for diagnosis and therapy of allergic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

Protein Modeling by E-mail

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01169.X

10.1046/J.1365-2222.2001.01169.X

21 January 2018

Identifiers

DOI

1 reference

16 June 2017

1 reference